Capital Planning & Strategy

Our biotech company side biotechnologies has been gearing at to raise capital and, uh, during our next stage of growth. And so we were really looking for a group that could help us understand our financial needs and, uh, could help us with our business development strategy going forward. And in particular, a group that had experience working with life science, startup companies, like ourselves.

Our first impression working with Richtr was that there was instant chemistry. They wanted to understand our business model, get to know our team, our technology, and overall, really understand the company’s mission and goals. They really helped us navigate and identify what we need financially to get our technology milestones met, to ultimately attract the right investor or strategic biopharma partner.

And this includes includes strategic advice, guidance and critical introductions to potential investors, potential, biopharma partners for, for SiVEC as well as future business and scientific advisors. So they also helped to keep our team aware of the competitive landscape. And they’ve also helped us prepare to pitch before investors and potential bio-pharma partners.

We absolutely see Richtr as a partner. In fact, we think of them as a part of our team. One of the ways in which they participate as a team member is often they will join in when we have virtual meetings with potential investors and biopharma partners.

We are so satisfied with the service and the consulting help that we’ve received from Richtr. We really look forward to working with them for many years to come as our company continues to grow. And we know that they’re going to be by our side during different stages of growth.

Lyndsey Linke, Ph.D., M.E.

Co-Founder & CEO

SiVEC Biotechnologies